Delivery Order SPE2DR25D1202-SPE2DR26F73MP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,868.18 to supply CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by December 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location, leveraging its established role as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a $7,979.16 delivery order to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-unit supply) on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military...
- The Defense Logistics Agency awarded a $1,278.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement with no set-aside designation. The delivery order has an ultimate completion date of July 23, 2025, with performance at the contractor's Conshohocken...
- The Defense Logistics Agency awarded a delivery order valued at $7,064.84 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 21 mg capsules (30-count units) under a firm fixed price contract. The award was made on November 25, 2025, with an ultimate completion date of November 26, 2025, and represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,502.21 to AmerisourceBergen Drug Corp for 30-count supplies of CAPLYTA 42 mg capsules, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The pharmaceutical product will be performed and delivered from the company's operations...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,537.51 to AmerisourceBergen Drug Corp for CAPLYTA 21 mg capsules (30-count supply) on December 26, 2025, with completion scheduled for December 29, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,077.05 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count) on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-set-aside, firm fixed-price contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-unit packages) with a ceiling value of $2,971.27 under firm fixed pricing. The award, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a $6,535.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). The contract, which is not set-aside, is scheduled for completion by November 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) with a ceiling value of $4,686.46. This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73MPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,074.72 to supply CAPLYTA 42 mg capsules (30-count units) under a firm fixed price contract, with a completion date of December 31, 2025. This non-set-aside award reflects competitive procurement of a branded pharmaceutical product for federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems, with extensive experience fulfilling federal procurement requirements across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive pharmaceutical and medical supply support for military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The DLA Troop Support is establishing the Pharmaceutical Prime Vendor Global Program Generation V with plans for multiple awards across separate regions, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/29/25 |